489 results
-
Ustekinumab for refractory Crohn's disease in pre-pubescent children
NHS England have launched a 30 day consultation on a proposal to not routinely commission ustekinumab to treat refractory Crohn's disease in pre-pubescent children. Related documents Policy Proposition Stakeholder Engagement Report Impact Assessment Evidence Review CPAG Summary Report Clinical Panel Report MoreClosed 1 November 2019 -
Vedolizumab for refractory ulcerative colitis in pre-pubescent children
NHS England have launched a 30 day consultation on a proposal to not routinely commission vedolizumab for refractory ulcerative colitis in pre-pubescent children. Related documents Policy Proposition Stakeholder Engagement Report Impact Assessment Evidence Review CPAG Summary Report Clinical Panel Report MoreClosed 1 November 2019 -
Dolutegravir-rilpivirine for treating HIV-1 in adults
NHS England has launched a 30 day consultation on commissioning dolutegravir-rilpivirine for treating HIV-1 in adults. Related documents Policy Proposition Stakeholder Engagement Report Impact Assessment Evidence Review CPAG Summary Report Clinical Panel Report MoreClosed 23 October 2019 -
Rituximab for refractory Systemic Lupus Erythematosus (SLE) in adults and post pubertal children
NHS England has launched a 30 day consultation on commissioning rituximab for refractory Systemic Lupus Erythematosus (SLE) in adults and post pubertal children. Related documents Policy Proposition Stakeholder Engagement Report Impact Assessment Evidence Review Evidence Report CPAG Summary Report Clinical Panel Report MoreClosed 23 October 2019 -
Dental services in Portsmouth, Alton and Tadley
We would like to hear your views on dental services in your area. We are planning to put in place some new contracts to provide dental services in Portsmouth, Alton and Tadley to replace services where dental contracts have recently ended. We would like your feedback so that this can be taken into account when putting in place new contracts. Thank you for your time in sharing your views with us. MoreClosed 21 October 2019 -
Haematopoietic stem cell transplantation for sickle cell disease for adults
NHS England has launched a four week consultation on a policy for the use of haematopoietic stem cell transplantation for sickle cell disease for adults. We have reviewed the evidence and are proposing that this treatment should be further considered for routine commissioning. Related documents Policy proposition Evidence review Stakeholder engagement report Clinical panel report CPAG summary report Integrated impact report MoreClosed 11 October 2019 -
Stereotactic Ablative Radiotherapy (SABR) for patients with metachronous extracranial oligometastatic cancer (all ages)
NHS England has launched a four week consultation on a policy proposition for the use Stereotactic Ablative Radiotherapy (SABR) for patients with metachronous extracranial oligometastatic cancer (all ages). The policy proposition has been developed in line with the findings of NHS England's SABR Commissioning through Evaluation (CtE) Programme, and after reviewing the evidence, NHS England are proposing to consider this treatment for routine commissioning. The draft CtE report for... MoreClosed 10 October 2019 -
Stereotactic Ablative Radiotherapy (SABR) for Hepatocellular Carcinoma (Adults)
NHS England has launched a four week consultation on a policy proposition for the use Stereotactic Ablative Radiotherapy (SABR) for the treatment of hepatocellular carcinoma (Adults). The policy proposition has been developed in line with the findings of NHS England's SABR Commissioning through Evaluation (CtE) Programme, and after reviewing the evidence, NHS England are proposing to consider this treatment for routine commissioning. The draft CtE report for the use of SABR in the... MoreClosed 10 October 2019 -
Special Care Dental Services in South West England
This survey is being carried out by NHS England and NHS Improvement to find out the views of patients, potential patients, parents, carers and advocates of the special care dental services that they commission in the South West of England: Cornwall and Isles of Scilly Devon Wiltshire Gloucestershire Bristol, North Somerset and South Gloucestershire (BNSSG) Somerset Responses will help us in the development of these services in the future. We are keen to... MoreClosed 4 October 2019 -
Kent and Medway Vascular Network Survey
As part of ongoing improvements to vascular services in Kent and Medway, we NHS England/Improvement, Specialised Commissioning, South East, welcome the opportunity to understand your experiences of this service, provided at Kent and Canterbury Hospital, Maidstone Hospital and Medway Maritime Hospital, Gillingham and would be grateful if you could complete this online survey. Please complete the survey by 30 September 2019. If you have any questions or need any further information... MoreClosed 30 September 2019 -
Sharing and Celebrating Patient and Public Involvement in Healthcare Community Grants
NHS England and NHS Improvement's 'celebrating involvement in healthcare' community grants scheme is now open for applications. Grants of up to £2500 are available to voluntary, community and social enterprise organisations to showcase how they have been involving patients, service users and the public in improving health services. MoreClosed 23 September 2019 -
Tell us what guidance you need on information sharing
Information governance is all about how to manage and share information appropriately. Many organisations have published guidance on information sharing in health and care, including guidance on how to use and share information to support the care of individuals, as well as for planning and research. NHSX - a new joint unit which is seeking to take forward digital transformation in the NHS - wants to bring all of this guidance together in one place, to simplify it, and to ensure that... MoreClosed 20 September 2019 -
Vonicog alfa for the treatment and prevention of bleeding in adults with von Willebrand disease
NHS England has launched a 30 day consultation on the use of vonicog alfa for the treatment and prevention of bleeding in adults with von Willebrand disease. Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report CPAG summary report Clinical panel report MoreClosed 18 September 2019 -
Dental services in Kent
We would like to hear your views on dental services in your area. We are hoping to put in place some new contracts to provide dental services in parts of the South East Kent so your feedback will be taken into account when doing this. Thank you for your time in sharing your views with us. MoreClosed 16 September 2019 -
Maternal intravenous immunoglobulin (IVIg) for the prevention of allo-immune fetal and neonatal haemochromatosis
NHS England has launched a 30 day consultation on a clinical policy proposition for maternal intravenous immunoglobulin (IVIg) for the prevention of allo-immune fetal and neonatal haemochromatosis. Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report CPAG summary report Clinical panel report MoreClosed 7 September 2019 -
Proton Beam Therapy for Children, Teenagers and Young Adults in the treatment of malignant and non-malignant tumours
NHS England has launched a six week consultation on a policy proposition for Proton Beam Therapy for Children, Teenagers and Young Adults in the treatment of malignant and non-malignant tumours. Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report CPAG summary report Clinical panel report MoreClosed 5 September 2019 -
Mercaptamine hydrochloride for corneal cystine deposits in people aged older than 2 years
NHS England has launched a 30 day consultation on the use of mercaptamine hydrochloride for corneal cystine deposits Related documents Policy Proposition Engagement Report Evidence Review Impact Assessment CPAG Summary Report MoreClosed 1 September 2019 -
Doravirine for the treatment of HIV 1 in adults
NHS England has launched a 30 day consultation on the use of doravirine for the treatment of HIV 1 in adults. Related documents Policy Proposition Engagement Report Evidence Review Impact Assessment CPAG Summary Report 1 CPAG Summary Report 2 MoreClosed 1 September 2019 -
Canakinumab for treating periodic fever syndromes: TRAPS, HIDS/MKD and FMF (ages 2 and older)
NHS England has launched a 30 day consultation on the use of canakinumab for treating periodic fever syndromes: tumour necrosis factor receptor associated periodic syndrome (TRAPS), hyperimmunoglobulin D syndrome/mevalonate kinase deficiency (HIDS/MKD) and familial Mediterranean fever (FMF). Related documents Policy Proposition Engagement Report Evidence Review Impact Assessment CPAG Summary Report MoreClosed 1 September 2019 -
Equality and Diversity in NHS Communications
As part of its on-going commitment to tackle equality and diversity issues, the London NHS Communications Network is inviting you to complete this survey. This survey aims to: Gather valuable insights from the NHS communications community that will inform what actions could be taken to address racial inequality and further promote equality in the NHS communications network. Gather a picture of who is currently working in our industry and what their roles entail. Reflect... MoreClosed 30 August 2019 -
Proposed changes to out of hours dental services in the West Midlands
This is a questionnaire in support of the c onsultation on proposed changes to ‘out of hours dental services in the West Midlands’. For full details of what is proposed please see the following: Needs Assessment (current services and future needs) Consultation Document (why we are consulting) Frequently asked questions Please note that these proposals do not affect existing in hours dental services provided through high street... MoreClosed 30 August 2019 -
Digital-first Primary Care: Policy consultation on patient registration, funding and contracting rules
All around us, a new generation of technology is changing our lives. Each year more of us choose online routes to book GP appointments, order repeat prescriptions or view personal health records. Digital innovations have the potential to support and empower patients, helping people to remain healthy and independent for longer. Used well, new technologies can also help to alleviate workload challenges in practices. The NHS Long Term Plan commits that every patient will... MoreClosed 23 August 2019 -
Ablative surgery, moulage technique brachytherapy and surgical reconstruction for head and neck soft tissue sarcoma in children and young people
NHS England has launched a 30 day consultation on a policy proposition for ablative surgery, moulage technique brachytherapy and surgical reconstruction for head and neck soft tissue sarcoma in children and young people. Related documents Policy proposition Evidence review Evidence report Impact assessment report Stakeholder engagement report CPAG summary report Clinical panel report MoreClosed 22 August 2019 -
Dexrazoxane for preventing cardiotoxicity in children and young people (< 25 years) receiving high-dose anthracyclines or related drugs for the treatment of cancer
NHS England has launched a 30 day consultation on a policy proposition for dexrazoxane for preventing cardiotoxicity in children and young people (< 25 years) receiving high-dose anthracyclines or related drugs for the treatment of cancer. Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report Clinical panel report CPAG summary report MoreClosed 22 August 2019 -
Idebenone for treating visual impairment in adults and young people with Leber's hereditary optic neuropathy
NHS England has launched a 30 day consultation on idebenone for treating visual impairment in adults and young people with Leber's hereditary optic neuropathy. Related documents Policy proposition Stakeholder engagement report Evidence review CPAG summary report Impact assessment report Clinical evidence evaluation MoreClosed 22 August 2019 -
Temozolomide as adjuvant treatment newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy (adults)
Temozolomide is an oral medicine that works by stopping cancer cells from making deoxyribonucleic acid (DNA), thereby preventing cell growth. It is proposed to be an additional adjuvant treatment option for people with newly-diagnosed anaplastic astrocytoma who have already been treated with surgery and radiotherapy. NHS England has launched a 30 day consultation on a policy proposition on commissioning the use of temozolomide as adjuvant treatment for adults with newly diagnosed... MoreClosed 10 August 2019 -
Survey on NHS Domiciliary Dental Services in Derbyshire and Nottinghamshire
The contracts to provide domiciliary dental services in the Derbyshire and Nottinghamshire are due to expire at the end of March 2020. NHS England and NHS Improvement - Midlands is planning to commission new contracts to continue provision of this service and would like to ask patients and other service users who access this service to give their feedback on the current services, to ensure that the domiciliary dental service provision will meet the needs of the local population it serves. ... MoreClosed 6 August 2019 -
Children's Cancer Services
NHS England has launched a 60-day consultation to seek views on proposed changes to children's cancer services. These are used by children aged between 0 and 16. In some cases, and with the agreement of Teenage and Young Adult's Cancer Services, they may also treat teenagers up to the age of 18. The aim of the service specifications is to improve the outcomes and experience of children and young people with cancer. This consultation guide sets out: How care is currently... MoreClosed 4 August 2019 -
Teenager and Young Adults Cancer Services
NHS England has launched a 60-day consultation to seek views on proposed changes to teenager and young adult's cancer services. These are used by teenagers and young people aged between 16 up to the day before their 25th birthday. In some cases, and with the agreement of Children's Cancer Services, they may also treat teenagers from the age of 13. The aim of the service specifications is to improve the outcomes and experience of teenagers and young adults with cancer. This... MoreClosed 4 August 2019 -
Telotristat for treating carcinoid syndrome diarrhoea (Adults)
NHS England has launched a 2 month consultation on a policy proposition for telotristat for treating carcinoid syndrome diarrhoea (Adults). Related documents Policy proposition Evidence review Evidence report Impact assessment report Stakeholder engagement report CPAG summary report MoreClosed 30 July 2019
489 results.
Page 7 of 17